Notably, the HLRCC tumors confirmed the hypermethylation seen in the TCGA study but no effect on CDKN2A mRNA expression was observed with the hypermethylated tumors having a greater expression that the unmethylated normal samples. This evidence concerns the gene CDKN2A and hereditary leiomyomatosis and renal cell cancer.